Abstract
Long-term adherence to carefully developed, individualized strategies is necessary for the optimum treatment outcomes in patients with atopic dermatitis (AD). However, the parents of children with AD frequently lack sufficient information about the disease and its treatment, hold incorrect and sometimes harmful beliefs about these issues, and too often do not follow through consistently with the treatment plan. The health care provider is the primary source of such education, so an effective provider relationship is fundamental to adherence. In addition to the provision of correct information and the correction of misinformation, clinicians must be aware of and must address barriers to adherence with AD therapy, especially parent anxiety about the safety of topical medications (corticosteroids and topical calcineurin inhibitors).
| Original language | English (US) |
|---|---|
| Journal | Seminars in Cutaneous Medicine and Surgery |
| Volume | 31 |
| Issue number | 3 SUPPL. |
| DOIs | |
| State | Published - Sep 2012 |
Fingerprint
Keywords
- Atopic dermatitis
- Psychiatric comorbidities
- Steroid phobia
- Treatment adherence
ASJC Scopus subject areas
- Dermatology
- Surgery
Cite this
Improving the Patient-Clinician and Parent-Clinician Partnership in Atopic Dermatitis Management. / Mancini, Anthony J.; Paller, Amy S.; Simpson, Eric; Ellis, Charles N.; Eichenfield, Lawrence F.
In: Seminars in Cutaneous Medicine and Surgery, Vol. 31, No. 3 SUPPL., 09.2012.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Improving the Patient-Clinician and Parent-Clinician Partnership in Atopic Dermatitis Management
AU - Mancini, Anthony J.
AU - Paller, Amy S.
AU - Simpson, Eric
AU - Ellis, Charles N.
AU - Eichenfield, Lawrence F.
PY - 2012/9
Y1 - 2012/9
N2 - Long-term adherence to carefully developed, individualized strategies is necessary for the optimum treatment outcomes in patients with atopic dermatitis (AD). However, the parents of children with AD frequently lack sufficient information about the disease and its treatment, hold incorrect and sometimes harmful beliefs about these issues, and too often do not follow through consistently with the treatment plan. The health care provider is the primary source of such education, so an effective provider relationship is fundamental to adherence. In addition to the provision of correct information and the correction of misinformation, clinicians must be aware of and must address barriers to adherence with AD therapy, especially parent anxiety about the safety of topical medications (corticosteroids and topical calcineurin inhibitors).
AB - Long-term adherence to carefully developed, individualized strategies is necessary for the optimum treatment outcomes in patients with atopic dermatitis (AD). However, the parents of children with AD frequently lack sufficient information about the disease and its treatment, hold incorrect and sometimes harmful beliefs about these issues, and too often do not follow through consistently with the treatment plan. The health care provider is the primary source of such education, so an effective provider relationship is fundamental to adherence. In addition to the provision of correct information and the correction of misinformation, clinicians must be aware of and must address barriers to adherence with AD therapy, especially parent anxiety about the safety of topical medications (corticosteroids and topical calcineurin inhibitors).
KW - Atopic dermatitis
KW - Psychiatric comorbidities
KW - Steroid phobia
KW - Treatment adherence
UR - http://www.scopus.com/inward/record.url?scp=84866859723&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84866859723&partnerID=8YFLogxK
U2 - 10.1016/j.sder.2012.07.003
DO - 10.1016/j.sder.2012.07.003
M3 - Article
C2 - 23021782
AN - SCOPUS:84866859723
VL - 31
JO - Seminars in Cutaneous Medicine and Surgery
JF - Seminars in Cutaneous Medicine and Surgery
SN - 1085-5629
IS - 3 SUPPL.
ER -